The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.

UAE lifts visa restrictions on Ugandan nationals
Dr Gargash highlights UAE's 'constructive role' in Russia-Ukraine-US trilateral talks
ADNOC L&S vessel sustains damage following attack
H.H. Sheikh Khaled, H.H. Sheikh Hamdan discuss key national priorities
Sheikh Abdullah attends third round of Russia-Ukraine-US trilateral talks
UAE completes critical design review of 'Sirb-1' satellite
UAE conditionally approves new use of Ultomiris for kidney disease patients
H.H. Sheikh Hamdan approves Dubai Metro extension to Al Maktoum Airport
UAE Year Of Award celebrates stronger families, community values
UAE President highlights nation's resilience during 'recent challenges'
H.H. Sheikh Khaled approves second package of Emirati Family Growth Programme
Sharjah approves housing support for 1,100 families
H.H. Sheikh Mohammed directs tents for 50,000 Gazans facing harsh weather
UAE postpones vehicle licensing limit for residents
New pedestrian bridge links Dubai Mall Metro Station and Coca-Cola Arena
High-achieving Union teams honoured at UAE Government Annual Meetings
Al Gergawi: UAE accelerates development with over AED 4 trillion in projects
Abu Dhabi launches lifestyle programme to help citizens get healthier
